We used the I-SceI endonuclease to produce DNA double-strand breaks (DSBs) and observed that a fraction of these DSBs were repaired by insertion of sequences, which we termed "templated sequence insertions" (TSIs), derived from distant regions of the genome. These TSIs were derived from genic, retrotransposon, or telomere sequences and were not deleted from the donor site in the genome, leading to the hypothesis that they were derived from reverse-transcribed RNA. Cotransfection of RNA and an I-SceI expression vector demonstrated insertion of RNA-derived sequences at the DNA-DSB site, and TSIs were suppressed by reversetranscriptase inhibitors. Both observations support the hypothesis that TSIs were derived from RNA templates. In addition, similar insertions were detected at sites of DNA DSBs induced by transcription activator-like effector nuclease proteins. Whole-genome sequencing of myeloma cell lines revealed additional TSIs, demonstrating that repair of DNA DSBs via insertion was not restricted to experimentally produced DNA DSBs. Analysis of publicly available databases revealed that many of these TSIs are polymorphic in the human genome. Taken together, these results indicate that insertional events should be considered as alternatives to gross chromosomal rearrangements in the interpretation of whole-genome sequence data and that this mutagenic form of DNA repair may play a role in genetic disease, exon shuffling, and mammalian evolution.
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polymorphism | TSIP | LINE-1 | DNA patch M aintenance of chromosomal integrity is critical to the survival of all organisms; thus the repair of DNA doublestrand breaks (DSBs) has been the subject of intense study (1, 2) . The principal forms of DNS-DSB repair in mammals are nonhomologous end joining (NHEJ), which can be divided into canonical (cNHEJ) and alternative NHEJ (aNHEJ) (3) and homologous recombination (HR). HR leads to an error-free repair of the DNA DSB but requires a sister chromatid to serve as the template for repair (4) . NHEJ does not require a sister chromatid for repair but is error-prone and thus is inherently mutagenic (1) .
Many cancers are associated with acquired gross chromosomal rearrangements (GCR), including translocation, inversions, and deletions (5, 6) . One proposed mechanism underlying these events is mistakes in NHEJ repair (5, 7) . To study GCRs in mammalian cells, the I-SceI endonuclease, which has an 18-bp recognition sequence not present in mice or humans, has been used to produce a single, specific DNA DSB within chromosomal DNA (8) (9) (10) (11) . Although some investigators were unable to recover GCRs by producing a single I-SceI-induced DNA DSB in mammalian cells (10) (11) (12) , several recent studies (8, 9, 13) have reported production of thousands of chromosomal translocations using I-SceI cleavage followed by anchored PCR and deep sequencing.
Several studies (11, 12, 14) have documented that transfected plasmid DNA can be captured and used as a patch at the site of I-SceI-induced DNA DSBs. These patches often show signs of aNHEJ, such as microdeletion, microhomology, and nontemplated nucleotide addition. Moreover, mitochondrial DNA fragments have been identified at the site of homothallic switching (HO) endonuclease-induced breaks (15) , further confirming the observation that DNA DSB can be repaired by insertion of DNA sequences.
RNA provides a template for DNA synthesis during reverse transcription of retroviruses and retrotransposons as well as during telomere elongation (16) . In Saccharomyces cerevisiae, DNA DSBs can be repaired by the insertion of endogenous Ty1 retrotransposons (15, 17) , and it has been suggested that endogenous retrotransposons, such as long interspersed element-1 (LINE-1), may have a role in DNA-DSB repair in mammalian cells. When supplied by a plasmid vector, the human LINE-1 ORF2 can mediate repair of HO endonuclease-induced DNA DSBs in S. cerevisiae via insertion of retrotransposon-or retrotransposon 3′-transduced cDNA sequences (18) . In these experiments, RNA served indirectly as a template for DNA-DSB repair through a cDNA intermediate. More recently, synthetic RNA oligonucleotides have been shown to serve as a template for DNA synthesis during repair of HO endonuclease-induced DNA DSBs in S. cerevisiae, albeit at a very low efficiency compared with DNA oligonucleotides (19) . Although there is no direct experimental evidence that mRNA or precursor mRNA (pre-mRNA) can serve as a repair template for DNA DSBs in mammalian cells (2) , a role for LINE-1 retrotransposons in DNA-DSB repair has been predicted (20, 21) . This prediction
Significance
We show that DNA double-strand breaks (DSBs) can be repaired by insertion of 50-to 1,000-bp sequences termed "templatedsequence insertions" (TSIs) derived from distant regions of the genome. Additional experiments indicate that the source of template for repair was primarily nuclear RNA. This mode of DNA-DSB repair by insertion is not restricted to experimentally produced breaks but also occurs at the site of spontaneous DNA DSBs in human cells. These TSIs are polymorphic in the human genome, suggesting that some TSIs occur in germ cells or embryos. Recognition of these TSIs is important in interpreting structural variations in short-read sequencing studies and provides additional polymorphic markers for population and evolution studies. This error-prone form of DNA repair may play a role in genetic diseases.
was based on the observation that new integration sites for an endonuclease-incompetent LINE-1 retrotransposon could be found in cultured rodent cells (21) . In those experiments, the integration sites lacked the typical hallmarks of integration induced by the LINE-1 integrase, such as target-site duplications (TSDs) and polyA tracts, leading to the prediction that LINE-1 sequences had become integrated during repair of a spontaneous DNA DSB.
Results

I-SceI-Induced DNA DSBs Can Be Repaired by Insertion of Sequences
Derived from Distant Regions of the Genome. To study the repair of DNA DSBs in vivo, we previously generated a vector (EF1aTK) containing the EF1a promoter driving expression of the herpes simplex thymidine kinase (HsTK); inserted between the EF1a promoter and HsTK cDNA was the recognition site for the rarecutting meganuclease I-SceI (Fig. S1A ). This vector was electroporated into the human monocytic leukemia cell line U937, and a clone (designated "F5") that had integrated a single copy of the EF1aTK vector was isolated (Fig. 1A) (11) . We attempted to induce reciprocal chromosomal translocations by introducing an I-SceI expression vector and using ganciclovir (GCV) to select clones that had lost expression of HsTK. The majority of the GCV-resistant clones identified had short deletions encompassing the HsTK start codon; however, we identified rare clones that had undergone an insertion of 47-756 bp that was not derived from nearby genomic sequences but instead was derived from a distant genomic region (11) .
To gain a greater understanding of these insertions, we transfected the F5 clone with an I-SceI expression vector, harvested genomic DNA, and amplified the region flanking the I-SceI site. The PCR products then were subcloned into a plasmid vector, and individual colonies were isolated (Fig. 1A) . We analyzed 120 samples; 10 (8.3%) were wild-type with an intact I-SceI site, 101 (84.2%) showed small (<50 bp) insertions or deletions (collectively designated "short indels"), 7 (5.8%) showed large (>50 bp) deletions, and 2 (1.7%) showed large (>50 bp) insertions.
Because insertion events were uncommon compared with short indels, we modified our experimental procedure by isolating a population of PCR products 50-to 1,500-bp larger than the wild-type EF1aTK allele to enrich for samples with insertions (SI Materials and Methods and Fig. 1A ). With this modification, the frequency of PCR products containing insertions was enriched substantially (from 1.8 to 7-18%), although many small indels (78-86%) and large deletions (2-7%) still were recovered. We identified 32 insertions derived from distant genomic regions in the F5 cells. To determine whether this phenomenon was unique to the F5 clone, we repeated the experiment with a clone (designated "A15") that had integrated a single copy of the EF1aTK vector into the ovarian cancer cell line OVCAR8 and again identified insertions derived from distant genomic regions. In all, 32 insertions from the F5 clone and 34 from the A15 clone were derived from distant regions of the genome (Dataset S1A). To distinguish these insertions from random, nontemplated nucleotide additions, we termed these insertions "templatedsequence insertions" (TSIs). One TSI from F5 cells and two TSIs from A15 cells were generated by the insertion of two unrelated fragments from distinct genomic origins. The lengths and distributions of the TSIs were similar in the two cell lines (P = 0.442, Student's t test) (Fig. 1B, Fig. S1B , and Dataset S1A). The TSI origins were mapped to 18 of 24 human chromosomes without any obvious preference for particular chromosomes or chromosomal regions (Fig. S1B ). More than half of the TSIs were derived from genic sequences (Fig. 1C) , and approximately one fifth of the TSIs were templated from LINE-1 or short interspersed element (SINE) sequences (Fig. 1D) . Junctions often showed features of aNHEJ, such as microhomology and nontemplated nucleotide addition (Fig. S1C) . These findings demonstrate that the use of TSIs to patch I-SceI-induced DNA DSBs is a reproducible form of DNA-DSB repair.
TSIs Are Not Unique to I-SceI-Induced Cleavage. Transcription activator-like effector nucleases (TALENs) are broadly applicable genome-editing tools (22) that produce site-specific DNA DSBs through the action of the FokI endonuclease (Fig. S1D) . To determine whether repair of DNA DSBs by TSI is unique to I-SceI-induced DNA DSBs, we used TALENs to create sitespecific DNA DSBs within the breast cancer 1 (BRCA1) and phosphatase and tensin homolog (PTEN) loci. Plasmids encoding TALENs for BRCA1 or PTEN were transfected into 293T or F5 cells, respectively. Genomic DNA was harvested and amplified with primers that flanked the TALEN cleavage site (Fig. S1D) . , and G418 R cassette (vertically striped box) are indicated. (Upper Right) Genomic DNA was PCR amplified using primers flanking the I-SceI site. PCR products were subcloned and transformed into bacteria, colonies were isolated, and inserts were PCR amplified. Alleles with an intact I-SceI site were identified by digestion with I-SceI, which cleaves the wild-type fragment into two comigrating fragments of ∼300 bp (arrowhead). To reduce background from short indels, we excised the portion of the gel indicated, ligated the population of fragments into plasmids, transformed bacteria, and isolated colonies, which were PCR amplified with I-SceI-flanking primers. Similar to the approach used in Fig. 1A , a region of the gel 50-to 1,500-bp larger than the wild-type, uncleaved fragment was excised and subcloned. Individual plasmids were sequenced, and, as shown in Fig. S1E , TALEN-induced DNA DSBs also were repaired by TSIs.
In addition to TSIs identified at experimentally induced DNA DSBs, there are rare, anecdotal reports consistent with insertions at the site of a physiologic DNA DSB, such as the IGH switch region in human B-lineage tumors (23) (24) (25) ; these findings are summarized in Dataset S2A. These observations support the hypothesis that the repair of DNA DSBs by TSIs is a generalizable phenomenon not restricted to repair of experimental DNA DSBs produced by endonucleases.
TSIs Used for DNA-DSB Repair Were Not Excised from the Genome.
To determine whether the TSI fragment had been excised from the genome and used to patch a DNA DSB, we evaluated four pure daughter clones (derived from the F5 or A15 cell lines) which contained experimentally induced TSIs. We generated primers that flanked the TSI donor sequence and amplified genomic DNA from the specific clone to determine if the donor sequence had been deleted. All four daughter clones showed a single, specific PCR product identical in size to the parental cell line, suggesting that the TSI donor region had not been excised from the genome (Fig. S2A ). It remained possible that a TSI donor allele had deleted more than 2 kb (a portion of which was inserted at the DNA-DSB site) and that the PCR product was amplified from the remaining intact allele. However, we identified an SNP within the 2-kb amplicon for clone 5T121; the nucleotide sequence of this SNP demonstrated that both alleles were retained (Fig. S2B ). In addition, in all four examples, quantitative PCR (qPCR) showed a copy number gain for the templated sequence, supporting the hypothesis that TSI donor regions were not excised from the genome (Fig. S2C) . We hypothesized that the TSIs used to repair the DNA DSBs were patches produced by reverse transcription of a nuclear RNA template. To test the hypothesis that RNA could be used as a template for DNA-DSB repair, we cotransfected human F5 cells with an I-SceI expression vector and murine RNA, which had been treated with DNase I to eliminate any contaminating genomic DNA (Fig. S3 A and B) , and isolated insertion events as described in Fig. 1A . We identified 102 clones with insertions; 92 clones had an insertion derived from a single donor site, nine clones had insertions derived from two donor sites, and one clone had an insertion derived from three distinct donor sites, leading to a total of 113 unique TSI events at the DNA-DSB site (Dataset S1B). Nine insertions matched murine sequences, suggesting that mRNA or pre-mRNA can be the underlying template for TSIs (Fig. 2) . Seven of the nine mouse TSIs were derived from genic sequences, but two were derived from intergenic regions and would not have been expected to be present in total RNA. However, RT-PCR experiments demonstrated that these sequences represented nonannotated transcribed regions (Fig. S3 C and D) . Unexpectedly, none of the insertions derived from murine RNA contained ribosomal RNA sequences, perhaps suggesting some specificity in the selection of the RNA template. Most (104/113) of the TSIs from the murine RNA cotransfection experiments were derived from endogenous human sequences; the size of the TSIs of human origin was 44-424 bp (Fig. S3E) , similar in size and distribution to the TSIs identified in our initial experiments. The inserted sequences originated from 23 of the 24 human chromosomes with no clear preference for any chromosome (Fig. S3F) . These results stand in contrast to insertions generated by replication fork stalling and strand switching, which preferentially insert nearby sequences derived from the same chromosome (26, 27) . Of note, four insertions displayed simple repeat sequences, including three samples with mammalian telomere repeat (TTAGGG)n sequences, suggesting that telomerase RNA also can be used as a template to patch a DNA DSB (Fig. S3G ).
Reverse-Transcriptase Inhibitors Can Suppress TSIs. LINEs are transposable elements that transpose not only LINE-1 RNA but also other elements such as SINEs (28) . In addition, the reversetranscriptase and endonuclease activity of the LINE-1 ORF2 has been proposed as a mechanism for the insertion of processed pseudogenes into the mammalian genome (29) . To determine whether suppression of endogenous reverse-transcriptase enzymes would reduce the frequency of DNA-DSB repair by TSI, we transfected the F5 clone with an episomal I-SceI expression vector and selected cells that had been successfully transfected with hygromycin. The culture was divided into two aliquots. One was treated with AZT and 2′, 3′-dideoxyinosine (ddI), which have been shown to inhibit LINE-1 and other endogenous reverse-transcriptase enzymes (30, 31) . The second aliquot was treated with vehicle alone. The concentrations of AZT and ddI used (3.7 and 4.2 μM, respectively) were below the AZT K i for POLA, POLB, POLG, and POLE (140, 290, 8.7, and 400 μM, respectively) (32) and were below the IC 50 for muscle cell proliferation (100 μM for AZT and 500 μM for ddI) (33) . Genomic DNA was harvested and amplified using primers that flank the I-SceI cleavage site. The region of the gel containing fragments 50-to 1,500-bp larger than the wild-type (uncleaved) fragment was excised, and the PCR products were subcloned. In each of four independent experiments, reverse-transcriptase inhibitor (RTI) treatment significantly reduced the frequency of TSIs after in vivo I-SceI cleavage ( Fig. S4 A and B) , supporting the hypothesis that the TSIs used to repair DNA DSBs are derived primarily by reverse transcription of RNA.
TSIs Can Be Identified at the Sites of Spontaneous DNA DSBs. To determine whether TSIs derived from distant genomic regions were limited to repair of experimentally induced DNA DSBs or instead represented a recurrent mechanism for repair of a spontaneous DNA DSB, we studied whole-genome sequence data from two human myeloma cell lines, KP6 (34) and MC1286PE1. We reasoned that repair of a spontaneous DNA DSB by a TSI would produce pairs of structural variation (SV) in the wholegenome sequence, and therefore we examined SVs in these two cell lines. From a total of 3,393 interchromosomal SVs in the KP6 cell line and 3,145 SVs in the MC1286PE1 cell line, we identified pairs of reciprocal fusion sequences (compared with the reference genome, GRCh37/hg19) that could represent interchromosomal TSIs by applying the following criteria: The two fusion junctions had to be located within 50 kb of one another; the strand polarity had to align so that an insertion was feasible; and the sequences had to map to a single unique region of the genome. A detailed analysis of one of these SVs is shown Mouse sequence insertion events in Fig. 3A . As outlined, although this pair of SVs could have been caused by a balanced translocation, the translocation would produce one dicentric chromosome and one acentric chromosome. We hypothesized that this pair of SVs instead was caused by an insertion of chromosome-4 sequences into chromosome 7, and we generated primers to test this hypothesis. As shown in Fig. 3 B and C, we were able to amplify this hypothetical TSI and verify that it indeed was produced by the insertion of chromosome-4 sequences into chromosome 7. Using this strategy, we verified 17 of 18 TSIs predicted from KP6 sequence data and 13 of 15 TSIs predicted from the MC1286PE1 sequence data ( Fig.  S5 and Dataset S2B).
Most TSIs Are Germ-Line Events and Represent Common
Polymorphisms in the Human Genome. Surprisingly, eight insertions were identical or nearly identical in the two cell lines (Dataset S2B), suggesting that these insertions represent polymorphisms in the human genome. To determine whether these TSIs were likely to be germ-line or somatic events, we compared the insertion junctions with a catalog of known SVs identified by the whole-genome sequence of 52 healthy individuals (SI Materials and Methods). SVs for 20 of the 23 unique TSIs were identified in this dataset, suggesting that most of the TSIs identified in the two myeloma cell lines represented germ-line polymorphisms rather than somatic mutations (Dataset S3A).
To confirm the findings from the whole-genome SV dataset, we used PCR to amplify the TSIs from a set of widely studied human cell lines (293T, U937, HL60, K562, and OVCAR8).
Nineteen of the 23 TSIs were PCR amplified from at least two independent cell lines, clearly demonstrating that these TSIs are polymorphic in human genomes (Dataset S3A); these polymorphic insertions are referred to as "templated sequence insertion polymorphisms" (TSIPs). Two TSIs were not found in the 52 individual databases or in cell lines but were found only in the KP6 cell line. These TSIs may represent somatic events, especially an 85-bp insertion of chromosome-1 sequence embedded at the junction of an acquired t(6;12) chromosomal translocation. Similar to our findings with the F5 and A15 daughter clones (Fig. S2) , the TSI donor sequences from these two potential somatic TSIs were not deleted from the genome, and the copy number of the TSI donor sequence was increased ( Fig. S6 A and B), as is consistent with the possibility of a somatic TSI. In addition, both TSI donor sequences were expressed in the KP6 cell line (Fig. S6C ).
TSIs Can Be Placed into Two Classes. Features of the 23 unique TSIs identified in the two myeloma cell lines are shown in Dataset S3B. The TSIs can be placed into two classes (class 1 and class 2) based on nucleotide sequences at or near the insertion. Class 1 TSIs displayed a TSD of at least 5 bp and the addition of nontemplated adenines (a polyA "tail") at one insertion junction. These class 1 TSIs typically inserted at a preferred LINE-1 retrotransposon integration site (consensus sequence 5′-TTTT/A-3′) and contained a polyadenylation signal (5′-AATAAA-3′) located 10-20 nucleotides upstream of the polyA track (Datasets S2B and S3B). Class 2 TSIs had none of these features but instead displayed aNHEJ features such as microdeletion, microhomology, and nontemplated nucleotide addition at the insertion sequence junction (Datasets S2B and S3B). The TSI origin and acceptor loci are shown as a Circos plot in Fig. 4A . Twelve of the TSIs represent class 1 events, eight represent class 2 TSIs, and the remaining three are ambiguous, because they lack either a TSD or a polyA addition. Class 2 TSIs were shorter (85-305 bp; median, 164 bp) than class 1 TSIs (160-3771 bp; median, 464 bp) (P = 0.024, Student's t test) ( Fig. 4B ) and were similar in size to our experimentally produced TSIs (Fig. 4B ). Genic regions were overrepresented compared with genomic composition and were preferentially used as templates (Fig. 4C) . We determined the frequency of the TSIPs identified in the two myeloma cell lines by examining SV data from the whole-genome sequences of 52 normal individuals (SI Materials and Methods). The prevalence of these TSIPs in the general population varied widely, from 0 to 98%, suggesting that both cell lines carried a unique combination of ancient, ancestral TSIPs and more recent, rare TSIPs (Fig. 4D ).
Discussion
We previously described moderate-sized (50-1,000 bp) insertions of sequences at an I-SceI-induced DNA DSB that were derived from distant regions of the genome (11). We designated these insertions "TSIs" to distinguish them from the wellrecognized nontemplated nucleotide addition that often accompanies NHEJ. Although the most common form of repair for experimentally (I-SceI) induced DNA DSBs was via small indels, a substantial (∼2%) fraction of repair events were made by TSIs. This phenomenon was not limited to I-SceI-induced DNA DSBs, because repair of TALEN-induced DNA DSBs also could be accomplished via TSI patches. Finally, we identified TSIs in the genomes of myeloma cell lines. Further investigation revealed that the majority of these TSIs in the human genome were TSIPs.
Reverse-transcribed retrotransposon sequences have been shown to patch DNA DSBs in yeast (17, 18) , and a role for retrotransposon RNA in DNA-DSB repair has been predicted in mammalian cells (20) . Furthermore, short RNA oligonucleotides have been shown to serve as templates for DNA-DSB repair in yeast (19) , and cellular mRNA was shown to mediate recombination in yeast (35) . These findings led us to suspect that the experimentally produced TSIs were derived primarily from nuclear mRNA or pre-mRNA. The observations that (i) DNA DSBs in a human cell line can be repaired by murine sequences when murine RNA is cotransfected, (ii) the genomic regions corresponding to the insertions are intact, and (iii) repair by insertion is inhibited by RTIs all support the contention that these experimentally produced TSIs were derived from RNA, as opposed to DNA, templates. Interestingly, small RNA species, although derived from local sequences near the DNA-DSB site rather than from more distant genomic regions, have been shown to be important for DNA-DSB repair (36) . An intriguing possibility is that the RNA source for the DNA-DSB patch is not necessarily derived from a distant genomic region but instead is derived from a gene that is cotranscribed with the EF1a-TK cassette, in a shared transcription factory (37) . In any event, our detection of insertions at the site of experimentally induced DNA-DSB repair supports the prediction, based on the detection of endonuclease-deficient LINE-1 insertions (20) , that reverse transcription of RNA transcripts can be used to repair spontaneous DNA DSBs. These findings are distinct from prior reports of retrotransposon-mediated DNA-DSB repair in S. cerevisiae (17) , in that the majority of experimentally produced TSIs in our study consist of genic regions rather than retrotransposon sequences. Similar to retrotransposon insertions (38) , this mechanism of DNA repair is mutagenic, because insertions that disrupt exons could compromise coding sequences, and the insertion of exonic regions could lead to the incorporation of alternate exons into mRNA. One insertion from the A15 cell line and three from the F5 cells consisted of (TTAGGG)n repeats, identical to mammalian telomere repeat sequence ( Fig. S3G and Dataset S1). Interstitial telomeric sequences (ITSs) have been reported in several species, including humans (39) , and it has been speculated that these insertions result from DNA-DSB repair (40) . However, ITS insertion at the site of a DNA DSB was not detected in a prior study that screened >300,000 repair events looking specifically for ITS insertions (41) . To our knowledge, this is the first direct experimental evidence documenting that telomere sequences can be used to repair DNA DSBs in mammals.
A large number of polymorphisms in human genomes have been identified and classified as SNPs, small (<50 bp) insertions or deletions (referred to collectively as short indels), and large (>50 bp) deletions. Analysis of the genomes of 1,092 individuals from 14 populations (the 1,000 Genomes Project) revealed 38 million SNPs, 1.4 million short indel polymorphisms, and 14,000 larger-deletion polymorphisms (42) . In addition, a large number of polymorphic LINE-1 or Alu elements have been cataloged (43) , and the presence of retroposed, processed gene transcript polymorphisms similar to processed pseudogenes has been predicted by analysis of SVs in the 1,000 Genomes Project (44) . However, the methods used to identify LINE-1 polymorphic insertions were designed to find LINE-1 insertion events (43) , whereas the methods used to identify polymorphic pseudogene insertions searched specifically for insertions of known exonic sequences (44) . Our method of identifying TSIPs is not biased toward a specific type of insertion sequence; in fact, most of the TSIP insertions we identified were derived from neither LINE-1 nor exonic sequences. Of note, as opposed to SNPs, which may be the result of independent, recurrent events (i.e., a C→T transition), it is highly unlikely that these TSIPs are recurrent events; instead, they likely represent unique founder events.
TSIPs could be placed into two classes based on nucleotide features of the insertion event. Class 1 TSIPs have all the hallmarks of a retrotransposon-induced event. The cleavage typically is at a preferred 5′-TTTT/A-3′ LINE-1 insertion site; TSDs (5-20 bp) are present, as is a polyA tract; and a polyadenylation signal is located within 20 bp of the polyA tract. The most obvious explanation for these observations is that nuclear RNA transcripts were acted upon by the LINE-1 ORF2 and inserted, through the action of LINE-1 endonuclease and reverse transcriptase, into a distant genomic locus. The RNA transcripts that produced class 1 TSIPs include transcripts known to be subject to LINE-1-mediated insertion events, including LINE-1/SINE insertion (n = 2) and processed pseudogenes type insertion (n = 5). Surprisingly, almost half (5/12) of the class 1 TSIPs were derived from intronic or intergenic sequences that had become polyadenylated, most likely by a cryptic polyadenylation signal (Datasets S2B and S3B). Thus, LINE-1-mediated mobilization of non-LINE-1 transcripts in a germ cell or embryo may occur more often than previously recognized.
In contrast, the class 2 TSIPs represent a previously unknown form of insertion polymorphism that does not show TSD, polyA tracks, or a preferred integration site (Dataset S3B). Instead, class 2 TSIPs show signs typically associated with aNHEJ, such as short deletions at the insertion site, short track microhomology, and the addition of nontemplated nucleotides at the insertion site. We suspect that the class 2 TSIPs were produced by a DNA DSB induced by physiologic or environmental DNA damage, followed by microhomology-mediated annealing of mRNA, reverse transcription, and healing of the DNA DSB. This latter mechanism produces nucleotide features similar to the TSIs seen at I-SceI-induced DSBs (lack of polyA sequence and presence of microhomology).
One important limitation of current deep-sequence studies is the relatively short read lengths (50-500 bp, using the most popular current platforms), which then are assembled by comparison with a reference sequence. Reads that map to two different chromosomal regions typically are cataloged as SVs. The presence of two reciprocal SVs often is suspected to represent a balanced chromosomal translocation (45, 46) but in fact may be an insertion, as demonstrated in Fig. 3 . Several recent papers (8, 9, 13) used I-SceI cleavage followed by anchored PCR to amplify sequences fused to the I-SceI cleavage site and deep sequencing to identify chromosomal translocations. However, those reports sequenced only small, short reads (the majority of reads containing <300 bp of fused sequence, well within the range of the TSI produced by I-SceI cleavage), making it difficult to rule out the possibility that the fusion sequences were generated by TSI repair rather than by chromosomal translocation. We believe that the interpretations of short-read deep-sequence data should consider the possibility of insertional events as alternatives to chromosomal translocations or other gross chromosomal rearrangements.
The findings reported here document that repair of DNA DSBs by insertions derived from distant genomic regions, which we term template sequence insertions, TSIs, are a common mode of repair for experimentally induced DNA DSBs. Moreover, we find evidence of numerous TSIs that are polymorphic in the human genome. Similar to retrotransposon insertions, we suspect that these TSIs, which represent a mutagenic form of DNA-DSB repair, may play a role in both the etiology of genetic diseases and mammalian evolution.
Materials and Methods
Cell Lines and DNA Transfections. The KP6 and MC1286PE1 cell lines have previously been published (34, 47) (Fig. 1) integrated into the U937 human monocytic leukemia cell line (F5) (11) and the OVCAR-8 human ovary cancer cell line (A15) (12) have been described previously. An episomal I-SceI expression vector that contained a hygromycin-resistant cassette (pCEP4-I-SceI) (11) was transfected together with total murine RNA (20-120 μg) into F5 or A15 cells and was selected with hygromycin. Genomic DNA was isolated 14-21 d after transfection.
Detection of I-SceI Cleavage Repaired by Insertion. Genomic DNA was PCR amplified using primers that flanked the I-SceI site and was size-fractionated on 1% agarose gels. A portion of the gel 50-to 1,500-bp larger than the wild-type PCR product, predicted to contain unique polyclonal fragments with insertions, was excised, cloned into plasmid vectors, and transformed into bacteria. Colonies with insertions at the I-SceI cleavage site were sequenced.
Detailed experimental procedures are shown in SI Materials and Methods. supplemented with 10% (vol/vol) FBS, 2 mM L-glutamine, 100 U/ mL penicillin, and 100 μg/mL streptomycin. 293T cells were cultured in DMEM supplemented with 10% (vol/vol) FBS, 2 mM L-glutamine, 100 U/mL penicillin, and 100 μg/mL streptomycin. Cells were maintained at 37°C in a humidified atmosphere of 5% (vol/vol) CO 2 . An episomal I-SceI expression vector that contained a hygromycin-resistant cassette (pCEP4-I-SceI) (1) was transfected together with total murine RNA (20-120 μg) into 2 × 10 6 cells using AMAXA Nucleofector (Lonza) reagents and protocols (F5: AMAXA Cell Line Nucleofector kit-C with W-01 program; A15: AMAXA Cell Line Nucleofector kit-V with V-01 program). Transfected F5 cells were cultured in a T75 flask with 400 μg/mL hygromycin B (Invitrogen) beginning 1 d after transfection. Transfected A15 cells were split into four 100-mm dishes 1 d after transfection and were treated with 200 μg/mL hygromycin B beginning 4 d after transfection. After drug selection, cells were harvested on day 14-21, and genomic DNA was isolated.
For reverse-transcriptase inhibitor (RTI) treatment, F5 cells were transfected with an I-SceI expression vector and split into two T75 flasks after transfection. One flask was incubated in the presence of RTIs [1 μg/mL AZT (Sigma-Aldrich) and 1 μg/mL 2′, 3′-dideoxyinosine (Sigma-Aldrich)] beginning immediately after transfection. Treatment with Hygromycin B (400 μg/mL) was begun 1 d after transfection to select for cells that had been transfected successfully with the episomal vector. Cells were harvested on day 14 by a laboratory colleague, and samples were designated "A" and "B" to keep the experiment blinded. Gancyclovir selection was not used in these experiments.
To obtain pure clones with insertions, 4 d after pCEP4-I-SceI transfection, F5 cells were diluted at 0.7 cells per well, seven cells per well, or 70 cells per well into 96-well plates with 400 μg/mL hygromycin B. For A15 clones, independent colonies were isolated after hygromycin B selection.
Preparation of Mouse RNA. Murine RNA was isolated from wildtype mouse spleen or a murine precursor T-cell lymphoblastic leukemia/ lymphoma cell line (no. 7298/2) (3) using TRIzol reagents and protocols (Life Technologies). The purified RNA was treated with DNaseI [DNA-freeTM; AMBION (Life Technologies)] to eliminate contaminating genomic DNA. Up to 20 μg of RNA was incubated in a volume of 20 μL with 2 U of DNase for 30 min at 37°C. DNase was inactivated by 2 μL of inactivation reagent (2 min at room temperature).
Detection of I-SceI Cleavage Repaired by Insertion. After transfection and selection with hygromycin, or in some cases with hygromycin and ganciclovir, 100 ng of genomic DNA was PCR amplified (annealing at 62°C, extension for 2 min, 30 cycles) using primers that flanked the I-SceI site and was size-fractionated on 1% agarose gels. The portion of the gel predicted to contain unique polyclonal fragments with insertions (50-to 1,500-bp larger than the wild-type PCR product) was excised and gel purified using the QIAquick Gel Extraction Kit (Qiagen). Purified products were cleaved with I-SceI endonuclease to eliminate wildtype PCR products with an intact I-SceI site and to enrich for PCR products with an insertion. After I-SceI cleavage, samples were ethanol precipitated and cloned into the pGEM-T easy vector (Promega). Ligated plasmids were transformed into DH5a-competent cells, which were plated on LB agar plates supplemented with ampicillin and X-Gal/isopropyl β-D-1-thiogalactopyranoside (ITI Scientific) for blue-white colony selection. White colonies were identified and used as a PCR template with primers that flanked the I-SceI site. PCR products were separated on 0.8% agarose gels, and the samples that showed PCR products larger than the wild-type parental F5 cell line were gel purified and sequenced. For experiments with the RTI treatment, the frequency of insertion was calculated as insertion frequency = clones with insertion/all clones analyzed.
Nucleotide sequences were determined by Sanger sequencing and capillary electrophoresis at the National Cancer Institute DNA core facility. The sequence data were compared with reference pEF1aTK vector sequences, and inserted fragments were identified. The inserted fragments were compared with the human and mouse genome assemblies (University of California Santa Cruz, February 2009 GRCh37/hg19 for human sequences and December 2011 GRCm38/mm10 for mouse sequences). All PCR amplifications, unless otherwise indicated, were performed using PCR SuperMix High Fidelity enzyme and buffers (Invitrogen).
Transcription Activator-Like Effector Nucleases. Transcription activator-like effector nuclease (TALEN) plasmids [breast cancer 1, BRCA1 (TAL2384, TAL2385) and phosphatase and tensin homolog, PTEN (TAL2344, TAL2345)] were obtained from Addgene. Then 2 μg of each TALEN plasmid pair was cotransfected with 0.5 μg of pmaxGFP into 293T cells or F5 cells using Lipofectamin 2000 (Life Technologies) or the AMAXA Nucleofector system, respectively. Successful transfection was verified by GFP fluorescence on day1, and transfectants were selected with Blasticidin S HCl (Life Technologies) at a concentration of 10 μg/mL. After 4-7 d of selection, pools of blasticidin-resistant cells were harvested, and genomic DNA was isolated. Genomic DNA was PCR amplified using primers flanking the TALEN-targeted sites (BRCA TAL forward: 5′-ACCCTCTGCTCTGGGTAAAGG-3′, BRCA TAL reverse: 5′-AGGTCCCATCCTCTCATACATACCA-3′; PTEN TAL forward: 5′-CTGCAACCATCCAGCAGCCG-3′, PTEN TAL reverse: 5′-CGCATCCGTCTACTCCCACG-3′). PCR products that contained insertions were isolated by size fractionation and gel excision as described above for the I-SceI-transfected cells.
Identification of Insertions from Whole-Genome Sequencing Data.
The myeloma cell line KP6 was obtained from Diane Jelinek (Mayo Clinic, Rochester, MN) (4), and the MC1286PE1 line was established from the pleural fluid of a patient with multiple myeloma at the Mayo Clinic Arizona. Whole-genome sequencing was performed on these two human myeloma cell lines by Complete Genomics (5). Complete Genomics structural variation (SV) analysis identified junctions between regions of the genome that are not adjacent on the reference genomes and were placed in an "allJunctionsBeta" file containing both highand low-confidence junctions. The KP6 cell line had 3,393 independent interchromosomal SVs, and MC1286PE1 had 3,145 independent interchromosomal SVs. If two interchromosomal SVs revealed close junction sites, those fragments were aligned and evaluated to determine if they might represent insertions or reciprocal translocations. Primers flanking the predicted insertion fragments were generated, and the potential insertions were validated by PCR amplification of the myeloma cell lines. Each PCR product was evaluated by Sanger sequencing as described above.
Analysis of Copy Number Variation by Quantitative PCR. Primers targeting templated-sequence insertions (TSI) were designed within the TSI sequence. Quantitative PCR (qPCR) was performed using Power SYBR Green PCR Master Mix (Applied Biosystems) and a 7500 Fast Real-Time PCR system (Applied Biosystems). For F5 and A15 daughter clones, threshold cycle (Ct) values were calibrated to albumin (6) and then were normalized to parental cells. For the KP6 cell line, copy numbers of upstream and downstream regions flanking the TSI were compared with that of the TSI sequence. Ct values were calibrated to albumin [confirmed by two copies in the KP6 cell line by wholegenome sequence copy number variation (WGS CNV) analysis and array comparative genomic hybridization (CGH)] and then were normalized to values from a diploid individual.
Frequency of the Insertion Polymorphisms. Each insertion was compared with the SV baseline genome set provided by Complete Genomics (B37baseline-junctions.tsv. available at www.completegenomics.com/sequence-data/download-data/). This baseline genome set comprises 52 genomes from normal, disease-free individuals representing a range of ethnicities and contains 39,595 independent structural variations with their frequency.
Statistical Considerations. The length of TSIs in the two groups (F5 vs. A15; class1 vs. class2) were compared by Student's t test. The frequency of insertions derived from genic and intergenic regions was compared with the human genome by normalizing the human genomic composition data from the ENCODE project consortium to the mean length of the inserted fragment and comparing the expected and observed genic and intergenic frequencies by a χ 2 goodness-of-fit test. The samples treated with RTI were compared with controls using a one-sided paired Student's t test. Fig. S4 . RTI treatment reduced the frequency of TSIs at I-SceI-induced DNA DSBs. (A) F5 cells were transfected with an I-SceI expression vector and treated or not treated with RTIs. Samples were evaluated for evidence of TSI using the gel-excision method described in Fig. 1A . The insertion ratio was calculated as number of TSIs/number of colonies analyzed. RTI treatment significantly suppressed insertion events. Results from four independent experiments are shown. P values were calculated using a one-sided paired Student's t test. (B) Results from four independent experiments: At least 70 colonies from RTI-treated (RTI tx) and untreated cultures were evaluated in each experiment.
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Chr2 into chr4 The genomic origins of two TSIs were PCR amplified using flanking primers. Both PCR products were identical in size to the reference sequence without showing an additional, smaller fragment representing a deletion. PCR products encompassing the donor origin were sequence verified. PCR was performed using Long Amp Taq (New England Biolabs) for "chr3 into 19 TSI." (B) WGS CNV analysis of the KP6 cell line showed two copies for the albumin (Alb) gene, five copies of chromosome 1 TSI origin, and two copies of chromosome 3 TSI origin; these values were identical to the gene copy number for these regions determined by array CGH. Because of limited resolution (2-kb window) of WGS CNV analysis, a gain of copy number at the TSI donor site was not detected. In both cases, CNV analysis by qPCR shows a gain of one copy of the TSI donor site compared with flanking regions. The green bar represents the TSI donor sequence, and the blue bars represent flanking regions FL1 and FL2. Error bars indicate SD. *P < 0.05, **P < 0.001, Student's t test. (C) KP6 cDNA was generated from DNase-treated RNA with or without reverse transcriptase. Expression of the TSI donor sequence was verified by RT-PCR using the primer sets used for CNV analysis. Note: this insertion event was identical between the two cell lines, excepting the number of nontemplated polyA nucleotides at the insertion. We suspect that this insertion originated in a single allele of a single germ cell, and the polyA tract expanded or shrunk over generations. TGTTCAGGAAATATATTTTTTTTTTTAAAGAAATATATAACTATTTATTAACCACTGTTCAGTATTTACAATAAAGTA  AACAATATACAGTTGGATAACATTTTGATTACTACAAAGTTGTTCTTCCTGGCTTTTGCTGAACCAGTAAAGCAAA  CTCAAGATTGAGCCTCCATGTAATGAATTGGGGTAAAGAAAAAACATGCAGGTCAATAGGTTAGGTTACAAAAGG  TTGTTCACACATTTATGACAGCAGGTCCTAAACTGCCAACACCTCTAACCATCTGATTAGGTTTCTATGAGCCAAG  TCTTACATATTCCATTCATCATGACCTTTTAGTCAATGTAGCAACAGGGATTCCAACATTTTGCTAAGGAATGGCC  CGCTAGGGAAACTTTTAAATGTTCATTTAACTTAGTTTTGTTTAGCTAGTTAAAAACACACTACCATTTGTCTAGTT  TCCCTCATCTGGATGAGGAAACCTGCTGTGATGGCAGTGATAAAAATTTTTCCTTTTAGGAATTTTGCAAATAAAC  CACTGCAATTATAGACACTTTAAAATTATCCAATTTAAATTGTCCTATCTAGAATTACTTATTTCACTTGAAATGTAT  GGCTTCAGGAAAATTTTCAATTTAACTTGAAGGGATTATCTCTTATTTTGCTTGGAATAATGGCATCTCAGAAACAT  GGGTTTACCTGTGATTTTTTTGTTTGGGTGAATGCTTAAAAACAAAAAAAAATTTACATATGCATTTTATGGATACA  CACACACACACACACACACACACAAAACACGTAATAAATCTAGAATGGTCCTTAGGCTTATGAGAACACAAGTTT  TGACTGAGTAATGACTATGGACATTTCCCCCAACATTTAGAAAAGCTGTTCTTTAATGAAGAGGAAATGATATACC  ATGGTATCAAATGTTCTTTTCTGATAAAGGAAGCAACTACAGAAAGCTTTTATTTATTTGTTCAAAGTAACCAGTGC  TATGGATGCAAAAAACCCCCAACAACTCTTCCAACGCTACTTTCAAAACAAACATATCAAACTTGATTTTCATTAG  GATGTAGTTATTTTGTCACACTAGTAAATCAAAATCTAAGACCCAATTTTTATATATATATATAAATATATATAAAAA AACAATGTGAACAATTATTGAGCTTCATCTTCTGGACAAGAATGCCAAGTTAGTCTCTCTTCATAAAAAGCAATTA  CAATTTGAGGACACTTCATATTTGCCTCTTTCGCCAGCACCAAGTCTGCCTCATCTGAATCTTTC/CATTTCATGAG  AAACATCAATTCTCCACTGCTGTCTGTGGCACCAATTATTCTTTCAGGATCAAGACCTCTGGCAAATCCTCTTGGT  TTGTCAGC/AGCATCTCTTTTCTTCTTTGATTTGCTGTCATCAGATTCACTGTCAGATAAAGATTTTCTTTTTGTACC  ATCTTTTTCTTTGCCAGCTTTCTGAGAGTTAAGAAACGCTTCAATCAATTCTGGACAATCTAAATTTTCTTCAGGTT  CCCAAGTATTGTCAGCA/TCTGTAAATCCCTTCCACTTCAGGAAATATTCCACTTTCCCATTCACTACACGTCGATC  TAGTACTTTTTCCACGACAAATTCTTCAGGCTCTGCCTCTTCAACTTTTTTACTCTTTCCATTCTGTTTTTTTCCCAT  TTTTTG/CAATGTAGTTTTGTTGGAGGCCATTTTTTATTGCAGACTTGAAGAGCTATTA/TTCACCGCCTCCGAGCT  GCTCCGGGTCGCGGGTCTGCAGCGTCTCCGGCCCTCCGCGCCTACAGCTCAAGCCACATCCGAAGTCAGGAAA  TATTTTTAAAATAAAATGGCTAACAAGAGGCAGAATGAATCTTATGTCAATATGCTCCCATTCTCAACAATCAATCT  ATTTATGTAAGTTTTTCAAACTCCAGCATCAGAAATCCACATGTAGCCCTGGGGCCATCACATTTTCTTGCAGGAT  GGCATAAGGTTTAACACTTTTGAGTTATTTGAATATACGGGCAACCAACAGTAGGCAAGAGGGTTCTACAGAATG  CCAAG 5' primer Chr15: -40854190 (+ stand) TSD Non-templated polyA (-strand) 6/6 match polyadenilation signal Chr7: 26241365-26252971 (-strand), spliced cDNA TC "CAC" is missing between "T" and "C" compared to reference sequence. AA "CACAAA" is mission between "A" and "A" compared to reference sequence. TCAGAGAAACAATGAGGTCTCTTTTGTTGTTGTTTTTTTTTTTTTTTTTCAGTTCTCAGTCCTCTTTTTATTTGAATT  CTCAGCAATATTCACAGAATCATCACTCTCCTTGAAATACTTTCTTCCTACTTCACTGGCCTCTTCTCACTCTCCTT  TGCTAGGTTACTCTGCCCCTTTCCATCCTCTAAAGTTGGGAGAACTCCAGGATTTGGTCCTTGGTACACTTTGAA  TATATTCCCTCCCTAAGCAGCTCATCCGGTTCTGTGGATTTATATACACACGGTACACAGTGAAAGGCTGGTATA  CATTTCAGAGTCAATGGCATACATAAGGCTGACTACAGCTTTACTTTGAAAAACAAAAGCTAAGTATCTTAACATT  TTATTTTACATTATATTTAATAAAAATTATACTTACAACTACCCAGTAACTCCTAGAACAAGGACAAACTCAAGTTTT  GTTTTGGTGACAGTTTTCTGACAAGATTAATAGAGCACAATGGACAGGTCCCCCATTTCACTTTCAAGGAACAAT  CATAAAACAGGGTAATCTTTACTGCATCAAATTCCCAGAACTACGCCTTTGAAGTAAGTTGACATAATACTTGTTG  TTTCTTCTCAAATTTTTAATGGTTCTCCACAGTATGCTAGGTCCTTATTTTCTCATTGGCCGTAATTTGACAAGTTC  TCCAAAAGCACTATCATGAACTTAATTAGATAATACTTTCCAGCTGTACTTAAATCAGAAGGCTCGTAGGCCTGAT  AAGCAGGTCAACCTGAAGCTACCAGGCAGCTCTGGAGGCTCCCGTGGCCATAGCCAACAGTGCACAGGAGGGC  CCCTGGCCCAGGATGAGCCCTCAGAACCTTTTAGAGAGAGTGAAGGTCAGGGTCTACTGGGTGTCCAAGCTGC  AGAGTGGAGCGTGAGAGGGTCAGCTGCCATGTGATAGAAAGAGCTGACATAAGAGAAAAGACCCCCACACAGT  GAAAAGCTGGAAGAGAAACAAAACTCACAACCTGACAGCAGAGTTCCTGGTTCCAACTGTTGAGACCTGTCTCTA  CCTCCAATGGTCACAGTATATAGTTACCCAGGCCTGGAAATCTCCCTCTTTTCCTAATTAGTTTAACTGGTGTTCC  TGTTGTTTGCAAACAGCAACTGCATCTTCAGACAGCACTGAGCAAGTAAAAGGTGTGGGACGGTCCTGAAAGGA  GATGATGGGAAGGCAGAGCTGGCTGGCAGCAATGTCTCTCTGGCCAGAAGGTCAGGGGCGGCCTCATCTGAGT  AGCAAACACCTTTATATTTTTGAAATTACTTGTCCTACTTCCTGGTACTACTTAAACCATTCTGTTGATTAAGCTGG  GTAATTTAGTATCAATGAAACACTAATAATCCTTAAAGAGTGAATGACTGGGCTACATGTCAACAAGACTAAGGTT  AAACCTTATTGAAACTTCATAAAAAGCATATTATGATGTTAATGTTCATGTTTGTCTTTAAAATGGGTCAACGTTTA  AAGGGGGACAGAGGCAGGGCAATGTGAATGTTAAAATCGGTCCAGCTCGGCTTTCATCTCATTCTGTTCAGTTT  CTGTATTGGATAGATCCACTGGAATTT/CAGTTTTCTTTGTTGCTGACATCTCGGATGTTCTGTCCATGTTTAAGGA  ACCTTTTACTGGGTGGCACTGCTTTAATTGCTATTGGAGTAGCTAGGTTTGAGTTGTATTTTGATAAAAG/CTGGA  GAATATCTTCTGGAATTTTAGTTACTTCTGGAGGTGTAGGTGTTCTGAGCAGATTCTCATAAGAAGAAATCGTAGG  TGAAGAGGGATCTGTTAAATTCTCAAAGCATGTGTCTGAATTTAAAACCAACGAAGTACGATCTTCAACTTCCAAA  TCATTTGATGAACTATTTGTTTTTGATAATGGGTAATTTGTGGATAC/CAAAGCTATGCTGTTCTTTGTAGATGGAA  TTTTCAAACCAGGAGTACAGAATGTAGGTACCAAAGGAGAGTTGGTATATTCGGCAT/CACTTTTTTCCAACTGCT  GGATGATGGGGCTGGGAGTGGCAAAAACATTATCATTGAGCCTGGATTCTGTATCTATGGCCTCCTCA/CTTTTAT  TATTCCTCGCATTTTTAAGTCCCATTGTGTAATCTTCATTTAAACACATAGTATATTCAGAGATACCAAAGTGTTCT  AATTTAGGAGTTACACACTCAAAATCATCCATTTTTAGTGCACATTTTGGAGTTTTTAGTACTTTTACTAGTGATTG  TTTGGTAGGTGGGGTTACAATTATGGGCTCTTCCTTATAGTTGTTCACTGCCTGTGGAGGGTTTGGTAGAACTTG  GGATACGATGTACCGCTCAAGTCCAAAATCTGAAAGTTGTGGACTACGTGGAGACTTCTCAGAAATACAACTGCT  TGCAACAGGAGGATCAGACAGATCATCTTTCACATCAGTCTTCTGAAAATTTTCACAATTAGACAACTCTGGGTCA  GAGTTAATGGCTTCTTGCTCGTGTA/CTGAATTTTTCTTGACACGTGGACTATATCCATACTTCTGGAAATACTCTC  TTATTTTCATAATATCCATTGAATTTTTTTCCATTAGTACTTTTGTTGCCTTTATGAAATCAATGCCTTCTT/ 
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